Analysis of data from a national childhood-onset diabetes register showed that a significant and clinically meaningful decrease of HbA1c level in pediatric patients with type 1 diabetes was associated with treatment modality during a 12-year period, according to research published in Diabetes Technology & Therapeutics.

Click here to read the full article.